AzTrials
AzTrials

Physical ActivityPACESNCT03060941

Promoting Activity in Cancer Survivors

A study testing Physical activity education, Facility access and Supervised exercise sessions in people with Physical Activity and Breast Cancer, run by University of Texas Southwestern Medical Center at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

A randomized multi-component physical activity intervention for breast cancer survivors. Read more about this study

Who is it for?
Ages 18 years and older, women only
Conditions the study is for
Physical Activity, Breast Cancer
What is being tested?
Physical activity education, Facility access and Supervised exercise sessions
Could I receive a placebo?
No, everyone receives an active treatment
How many people
355 participants
Where
1 siteUnited States
Study dates
4 Dec 2017to 28 Feb 2020
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • Women only
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • breast cancer survivors between 3 months and 5 years post-treatment
  • report <150 minutes of moderate-to-vigorous physical activity (MVPA) on the GPAQ
  • physically able to engage in physical activity

Who cannot join

  • medical condition contraindicating physical activity participation
  • cognitively unable to give informed consent

Trial locations and contacts

1 site in 1 country.

United States1 site
  • UT Southwestern Medical Center

    Dallas, Texas, 75235

Other trials in United States

About this study

A randomized multi-component physical activity intervention for breast cancer survivors.

Read the detailed description

The research project is a study to assess the effects of a multi-component intervention in increasing physical activity among breast cancer survivors. Individuals meeting inclusion/exclusion criteria will be randomized to one of sixteen intervention groups for the 6 months. Intervention components will include print-based education, self-monitoring, Active Living counseling, supervised exercise sessions, and facility access. Blood samples will be collected at baseline. Assessments (anxiety, stress, sleep) and sample collection will also occur at 3 time points during the intervention (Weeks 13 and 25). Changes in physical activity will be assessed for each intervention group.

Being tested
Physical activity education, Facility access, Supervised exercise sessions, Self-monitoring (Fitbit), Active living counseling
Medical subject headings
Motor Activity, Breast Neoplasms

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Physical activity educationBehavioural

    Participants will be given educational materials on how to increase physical activity levels.

  • Facility accessBehavioural

    Participants will receive at 6 month membership to a local fitness facility.

  • Supervised exercise sessionsBehavioural

    Participants will attend weekly supervised exercise sessions with an exercise interventionist.

  • Self-monitoring (Fitbit)Behavioural

    Participants will be given a Fitbit to monitor their physical activity levels.

  • Active living counselingBehavioural

    Participants will attend 12 biweekly educational sessions about how to increase their physical activity levels.

Study groups in NCT03060941
Study groupRoleWhat they receive
Group 1ExperimentalPhysical activity education
Receives: Behavioral: Physical activity education
Group 2ExperimentalPhysical activity education and facility access
Receives: Behavioral: Physical activity education; Behavioral: Facility access
Group 3ExperimentalPhysical activity education and supervised exercise sessions
Receives: Behavioral: Physical activity education; Behavioral: Supervised exercise sessions
Group 4ExperimentalPhysical activity education and self-monitoring (Fitbit)
Receives: Behavioral: Physical activity education; Behavioral: Self-monitoring (Fitbit)
Group 5ExperimentalPhysical activity education and active living counseling
Receives: Behavioral: Physical activity education; Behavioral: Active living counseling
Group 6ExperimentalPhysical activity education, facility access, and supervised exercise sessions
Receives: Behavioral: Physical activity education; Behavioral: Facility access; Behavioral: Supervised exercise sessions
Group 7ExperimentalPhysical activity education, facility access, and self-monitoring (Fitbit)
Receives: Behavioral: Physical activity education; Behavioral: Facility access; Behavioral: Self-monitoring (Fitbit)
Group 8ExperimentalPhysical activity education, facility access, and active living counseling
Receives: Behavioral: Physical activity education; Behavioral: Facility access; Behavioral: Active living counseling
Group 9ExperimentalPhysical activity education, supervised exercise sessions, and self-monitoring (Fitbit)
Receives: Behavioral: Physical activity education; Behavioral: Supervised exercise sessions; Behavioral: Self-monitoring (Fitbit)
Group 10ExperimentalPhysical activity education, supervised exercise sessions, and active living counseling
Receives: Behavioral: Physical activity education; Behavioral: Supervised exercise sessions; Behavioral: Active living counseling
Group 11ExperimentalPhysical activity education, self-monitoring (Fitbit), and active living counseling
Receives: Behavioral: Physical activity education; Behavioral: Self-monitoring (Fitbit); Behavioral: Active living counseling
Group 12ExperimentalPhysical activity education, facility access, supervised exercise sessions, and self-monitoring (Fitbit)
Receives: Behavioral: Physical activity education; Behavioral: Facility access; Behavioral: Supervised exercise sessions; Behavioral: Self-monitoring (Fitbit)
Group 13ExperimentalPhysical activity education, facility access, supervised exercise sessions, and active living counseling
Receives: Behavioral: Physical activity education; Behavioral: Facility access; Behavioral: Supervised exercise sessions; Behavioral: Active living counseling
Group 14ExperimentalPhysical activity education, facility access, self-monitoring (Fitbit), and active living counseling
Receives: Behavioral: Physical activity education; Behavioral: Facility access; Behavioral: Self-monitoring (Fitbit); Behavioral: Active living counseling
Group 15ExperimentalPhysical activity education, supervised exercise sessions, self-monitoring (Fitbit), and active living counseling
Receives: Behavioral: Physical activity education; Behavioral: Supervised exercise sessions; Behavioral: Self-monitoring (Fitbit); Behavioral: Active living counseling
Group 16ExperimentalPhysical activity education, facility access, supervised exercise sessions, self-monitoring (Fitbit), and active living counseling
Receives: Behavioral: Physical activity education; Behavioral: Facility access; Behavioral: Supervised exercise sessions; Behavioral: Self-monitoring (Fitbit); Behavioral: Active living counseling

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Moderate-to-vigorous physical activity measured by Actigraph accelerometer

    Measure physical activity at baseline and follow-up periods (3- and 6-months post-baseline) and assess percentage of survivors meeting physical activity guideline recommendations.

    Measured: 24 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted23 Feb 2017
  2. Study start4 Dec 2017
  3. Primary completion28 Feb 2020
  4. Study completion28 Feb 2020

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Model description
The 500 participants in the physical activity intervention will be randomly assigned to one of sixteen intervention groups (see Table below). Randomization will be stratified by clinical site. The randomization scheme will be conducted by the study statistician. The randomization scheme will consist of balanced blocks within each stratum, with block size will be varied and randomly permuted. Allocation will occur following completion of baseline assessments.
Masking
None (open label)
Enrolment
355 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03060941
Sponsor's protocol ID
STU 092016-004
Acronym
PACES
Status last verified
Jan 2021
First submitted
17 Feb 2017
Last updated
26 Jan 2021
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Rethorst CD, Carmody TJ, Argenbright KE, Mayes TL, Hamann HA, Trivedi MH. Considering depression as a secondary outcome in the optimization of physical activity interventions for breast cancer survivors in the PACES trial: a factorial randomized controlled trial. Int J Behav Nutr Phys Act. 2023 Apr 20;20(1):47. doi: 10.1186/s12966-023-01437-x.

    PubMed 37081460
  • Rethorst CD, Hamann HA, Carmody TJ, Sharp KJ, Argenbright KE, Haley BB, Skinner CS, Trivedi MH. The Promoting Activity in Cancer Survivors (PACES) trial: a multiphase optimization of strategy approach to increasing physical activity in breast cancer survivors. BMC Cancer. 2018 Jul 18;18(1):744. doi: 10.1186/s12885-018-4662-5.

    PubMed 30021554

Questions about this trial

What is this clinical trial studying?

A study testing Physical activity education, Facility access and Supervised exercise sessions in people with Physical Activity and Breast Cancer, run by University of Texas Southwestern Medical Center at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 26 Jan 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Moderate-to-vigorous physical activity measured by Actigraph accelerometer (time frame: 24 weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03060941, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 Jan 2021.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in